Viewing Study NCT00220025



Ignite Creation Date: 2024-05-05 @ 12:03 PM
Last Modification Date: 2024-10-26 @ 9:19 AM
Study NCT ID: NCT00220025
Status: COMPLETED
Last Update Posted: 2012-10-25
First Post: 2005-09-20

Brief Title: Narrowband UVB Light Therapy to Patients With Dark Skin Types Who Have 10 of Their Body Involved With Psoriasis Vulgaris
Sponsor: Mary Sullivan-Whalen
Organization: Rockefeller University

Study Overview

Official Title: A Study To Determine the Efficacy of Whole Body Narrowband UVB Phototherapy in People With Darker Skin Types
Status: COMPLETED
Status Verified Date: 2012-10
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: This study offers narrowband UVB light therapy to patients with both light and dark skin types who have 10 of their body involved with psoriasis vulgaris
Detailed Description: Two groups of patients having 10 of their body surface area involved with psoriasis vulgaris will receive narrowband phototherapy One group will have skin type I-IV or light skin and the second group will have dark skin or type V-VI

All patients will receive phototherapy with narrowband UVB three times a week for six weeks or a total of 18 treatments 6mm punch skin biopsies will be done prior to starting therapy and at the completion of the study Clinical assessments and photography will be done parallel to the skin biopsies Results clinically and histologically of both groups will be compared

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None